Establishment Labs (NASDAQ:ESTA) Hits New 1-Year High – Here’s Why

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $78.25 and last traded at $75.3890, with a volume of 77915 shares traded. The stock had previously closed at $76.00.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Mizuho lifted their price target on Establishment Labs from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Citigroup increased their price target on Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $84.00 price target on shares of Establishment Labs in a report on Monday, January 12th. JPMorgan Chase & Co. upped their price objective on shares of Establishment Labs from $71.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Finally, BTIG Research increased their price objective on shares of Establishment Labs from $81.00 to $86.00 and gave the company a “buy” rating in a research report on Wednesday, December 31st. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $78.86.

Establishment Labs Stock Down 1.2%

The firm has a 50-day simple moving average of $70.82 and a 200 day simple moving average of $57.14. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10. The stock has a market capitalization of $2.18 billion, a P/E ratio of -26.51 and a beta of 0.99.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Nantahala Capital Management LLC grew its holdings in Establishment Labs by 11.1% in the third quarter. Nantahala Capital Management LLC now owns 1,973,492 shares of the company’s stock worth $80,893,000 after purchasing an additional 197,962 shares during the period. Bamco Inc. NY increased its position in shares of Establishment Labs by 30.2% during the third quarter. Bamco Inc. NY now owns 1,181,824 shares of the company’s stock worth $48,443,000 after acquiring an additional 274,287 shares in the last quarter. Tyro Capital Management LLC lifted its stake in Establishment Labs by 1.0% during the 3rd quarter. Tyro Capital Management LLC now owns 1,077,456 shares of the company’s stock valued at $44,165,000 after acquiring an additional 10,735 shares in the last quarter. William Blair Investment Management LLC grew its stake in shares of Establishment Labs by 17.6% in the 3rd quarter. William Blair Investment Management LLC now owns 1,017,543 shares of the company’s stock worth $41,709,000 after acquiring an additional 152,299 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Establishment Labs by 117.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 811,536 shares of the company’s stock valued at $59,145,000 after purchasing an additional 438,206 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.